股份回购注销

Search documents
山东路桥: 关于注销回购股份减少注册资本暨通知债权人的公告
Zheng Quan Zhi Xing· 2025-05-19 13:38
Group 1 - The company plans to repurchase its A-shares using self-owned funds or loans from financial institutions, with the repurchased shares to be canceled and the registered capital reduced accordingly [1][2] - The total amount of funds for the repurchase is estimated to allow for the acquisition of approximately 5,760,369 to 11,520,737 shares, which represents about 0.37% to 0.74% of the company's current total share capital [1][2] - The maximum repurchase price is set at 8.68 yuan per share, and the company will disclose updates on the repurchase progress and completion [1][2] Group 2 - Creditors have the right to claim their debts or request guarantees within 45 days from the announcement date, and failure to do so will not affect the validity of their claims [2] - Creditors must provide original and copies of documents proving the existence of the debt relationship when submitting claims, and specific procedures for claims submission are outlined [2] - The announcement specifies that the date of mailing or postmark will be considered as the submission date for claims [2]
惠威科技: 关于回购股份注销完成暨股份变动的公告
Zheng Quan Zhi Xing· 2025-05-19 10:34
证券代码:002888 证券简称:惠威科技 公告编号:2025-018 广东惠威电声科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 特别提示: 办理完毕上述回购股份的注销手续。 一、回购股份的实施情况 公司于 2021 年 6 月 28 日召开第三届董事会第十一次会议审议通过了《关于回购公 司股份方案的议案》,以自有资金回购公司股份,并将回购股份用于实施公司员工持股 计划或者股权激励。回购股份价格不超过人民币 16 元/股,回购股份的资金总额不低于 人民币 3,000 万元,且不超过人民币 6,000 万元。具体情况详见公司刊登于巨潮资讯网 的公告:《关于回购公司股份方案的公告》(公告编号 2021-032)、《回购报告书》(公 告编号 2021-036)。 公司累计通过股份回购专用证券账户以集中竞价方式回购公司股份 2,567,040 股, 占本次注销前公司总股本的 1.72%,最高成交价为 12.78 元/股,最低成交价为 9.74 元/ 股,支付的总金额为 30,000,557.33 元(不含交易费用),成交均价为 11.67 元/股。 ...
永泰能源: 永泰能源集团股份有限公司关于2024年年度股东大会增加临时提案的公告
Zheng Quan Zhi Xing· 2025-05-19 10:23
A股 600157 永泰能源 2025/5/22 二、 增加临时提案的情况说明 证券代码:600157 证券简称:永泰能源 公告编号:临 2025-033 永泰能源集团股份有限公司 关于2024年年度股东大会增加临时提案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、 股东大会有关情况 股份类别 股票代码 股票简称 股权登记日 公司已于2025 年 4 月 29 日公告了股东大会召开通知,单独持有公司18.13%股 份的控股股东永泰集团有限公司,在2025 年 5 月 17 日提出临时提案并书面提交股 东大会召集人。股东大会召集人按照《永泰能源集团股份有限公司股东大会规则》 有关规定,现将临时提案有关内容予以公告。 根据《公司法》《永泰能源集团股份有限公司章程》(以下简称《公司章程》) 的有关规定,永泰集团有限公司提请在公司 2024 年年度股东大会增加审议《关于 公司回购股份用于注销以减少注册资本的议案》,具体内容如下: 为稳定公司股价,增强公众投资者对公司的信心,推动公司股价合理回归,维 护广大投资者尤其 ...
德邦股份: 德邦物流股份有限公司关于注销回购股份并减少注册资本暨通知债权人的公告
Zheng Quan Zhi Xing· 2025-05-16 12:15
证券代码:603056 证券简称:德邦股份 公告编号:2025-024 德邦物流股份有限公司 关于注销回购股份并减少注册资本 暨通知债权人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原由 德邦物流股份有限公司(以下简称"公司")于 2025 年 4 月 24 日召开第六 届董事会第五次会议,审议通过了《关于以集中竞价交易方式回购股份预案的议 案》(以下简称"本次回购方案"),详见公司于 2025 年 4 月 25 日在上海证券 交易所网站(www.sse.com.cn)披露的《德邦物流股份有限公司关于以集中竞价 交易方式回购股份的预案》(公告编号:2025-013)。公司于 2025 年 5 月 16 日召开 2024 年年度股东会,会议逐项审议并通过了上述议案,详见公司于 2025 年 5 月 17 日在上海证券交易所网站(www.sse.com.cn)披露的《德邦物流股份 有限公司 2024 年年度股东会决议公告》(公告编号:2025-023)。 根据本次回购方案,公司拟使用自有资金以集中竞价交 ...
优博讯:部分回购股份注销完成,总股本变更为3.22亿股
news flash· 2025-05-14 11:44
Core Viewpoint - The company has announced the cancellation of 5.6449 million shares, which represents 1.72% of the total share capital prior to the cancellation [1] Summary by Relevant Sections - **Share Cancellation Details** - The number of shares being cancelled is 5.6449 million [1] - After the cancellation, the total share capital will decrease from 328 million shares to 322 million shares [1] - **Regulatory Compliance** - The cancellation of shares complies with relevant laws, regulations, and the company's articles of association [1] - **Impact on Financials** - The share cancellation will not have a significant impact on the company's financial condition and operating results [1]
皮阿诺: 关于回购股份注销完成暨股东权益变动的公告
Zheng Quan Zhi Xing· 2025-05-14 10:26
证券代码:002853 证券简称:皮阿诺 公告编号:2025-030 广东皮阿诺科学艺术家居股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 重要提示: 股,导致公司控股股东、实际控制人马礼斌先生及其一致行动人马瑜霖女士的持 股比例由 38.75%增加至 39.52%;导致公司持股 5%以上股东珠海鸿禄企业管理合 伙企业(有限合伙)及其一致行动人保利(横琴)资本管理有限公司-共青城齐 利股权投资合伙企业(有限合伙)的持股比例由 13.76%增加至 14.03%。 公司因实施注销回购股份导致公司总股本、无限售条件流通股数量发生变化, 根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所上 市公司自律监管指引第 9 号——回购股份》等相关规定,现就回购股份注销完成 暨股东权益变动的情况公告如下: 一、本次回购股份的批准及实施情况 公司于 2021 年 5 月 24 日召开第三届董事会第八次会议,审议通过了《关于 回购公司股份方案的议案》,公司拟使用自有资金以集中竞价交易的方式回购公 司股份,并将用于实施公司员工持股计划或者股权激励,回购 ...
海泰新光: 海泰新光关于实施回购股份注销暨股份变动的公告
Zheng Quan Zhi Xing· 2025-05-12 13:20
Core Viewpoint - The company, Qingdao Haitai Newlight Technology Co., Ltd., has announced the cancellation of 737,000 shares, which represents 0.6110% of the total share capital prior to cancellation, following a decision to change the purpose of repurchased shares from employee stock ownership plans to cancellation and capital reduction [1][2][3]. Group 1: Share Repurchase and Cancellation - The company will cancel 737,000 shares from its repurchase account, reducing the total share capital from 120,614,000 shares to 119,877,000 shares [1][5]. - The cancellation date for the repurchased shares is set for May 13, 2025 [4]. - The repurchase was initially intended for employee stock ownership plans or equity incentives, but the purpose has been changed to cancellation and capital reduction [2][3]. Group 2: Approval and Notification Process - The decision to change the purpose of the repurchased shares and to cancel them was approved at the company's general meeting in March 2025 [2][3]. - The company has complied with legal requirements by notifying creditors about the cancellation and has not received any claims for debt repayment within the stipulated period [3][6]. Group 3: Impact on Company Structure - After the cancellation, the company's total share capital will be 119,877,000 shares, with the shareholding structure remaining compliant with listing requirements [5][6]. - The cancellation is expected to enhance investor confidence and will not significantly impact the company's financial status, operational results, or debt repayment capabilities [6].
广大特材: 关于控股股东、实际控制人及一致行动人免于要约收购暨权益变动触及1%的提示性公告
Zheng Quan Zhi Xing· 2025-05-12 11:42
证券代码:688186 证券简称:广大特材 公告编号:2025-047 转债代码:118023 转债简称:广大转债 ? 公司控股股东、实际控制人及一致行动人持股数量未发生变化,本次权 益变动不会导致公司控股股东、实际控制人发生变更。 ? 根据《上市公司收购管理办法》《上市公司股份回购规则》的有关规定, 本次权益变动属于可以免于发出要约的情形。 一、本次权益变动基本情况 公司分别于 2025 年 4 月 25 日、2025 年 5 月 12 日召开第三届董事会第十七 次会议、第三届监事会第九次会议、2024 年年度股东大会审议通过了《关于变 更部分回购股份用途并注销的议案》,同意将回购股份用途由"在未来适宜时机 用于股权激励及/或员工持股计划,或用于转换上市公司发行的可转换为股票的 公司债券"变更为"在未来适宜时机用于股权激励及/或员工持股计划,或用于 注销并相应减少注册资本",并将已回购的股份 8,000,000 股进行注销并相应减少 注册资本。具体内容详见公司分别于 2025 年 4 月 26 日在上海证券交易所网站 (www.sse.com.cn)披露的《关于变更部分回购股份用途并注销暨减少注册资本 的公 ...
股份回购注销以推动价值回归,业绩释放、药店经营改善或是关键催化剂
Xinda Securities· 2025-05-08 13:25
Investment Rating - The report assigns a "Buy" rating to the company, indicating that the stock price is expected to outperform the benchmark by more than 15% [14]. Core Views - The company is implementing a share buyback plan with a budget of up to HKD 100 million, which is seen as a catalyst for value recovery and performance release [1][4]. - The board believes the current stock price does not reflect the company's true value and is taking proactive steps to enhance shareholder returns while investing in long-term strategic initiatives [4]. - The company has demonstrated strong confidence in its long-term growth potential, as evidenced by recent share purchases by key executives [4]. Summary by Relevant Sections Company Performance and Market Position - The company has completed its warehousing and supply chain setup, with a cumulative registered buyer base of 827,000 by the end of 2024, including 491,000 pharmacies and 330,000 grassroots medical institutions [5]. - The company is expected to achieve a compound annual growth rate (CAGR) of 145% in net profit from 2024 to 2027, driven by improved profitability from exclusive brand partnerships and economies of scale [5][6]. Financial Projections - Revenue projections for 2025, 2026, and 2027 are approximately HKD 20.81 billion, HKD 23.48 billion, and HKD 26.49 billion, respectively, with year-on-year growth rates of 16%, 13%, and 13% [6][7]. - The net profit attributable to the parent company is expected to reach HKD 1.29 billion, HKD 2.75 billion, and HKD 4.41 billion for the same years, reflecting significant growth rates of 331%, 112%, and 61% [6][7]. Competitive Landscape - The company is navigating challenges in the pharmacy sector, including store closures, but is focusing on expanding its market share among grassroots medical institutions, which may provide new growth channels [5]. - The company has established a competitive edge through its supply chain and digital capabilities, positioning itself well against traditional distributors and e-commerce giants in the B2B pharmaceutical market [5].
遥望科技:拟注销856.75万股股份
news flash· 2025-04-29 08:14
遥望科技(002291)公告,公司拟将存放于回购专用证券账户中原计划"员工持股计划或股权激励计 划"的股份之用途变更为"用于注销以减少注册资本"。本次变更事项尚需提交公司股东大会审议。公司 于2022年4月12日召开第五届董事会第二次会议,审议通过了《关于以集中竞价方式回购公司股份方案 的议案》,同意使用自有资金以集中竞价交易的方式回购公司股份,用于实施股权激励计划或员工持股 计划,回购股份的种类为公司发行的人民币普通股(A股)。本次回购股份资金总额不低于人民币1.5亿元 (含)且不超过人民币3亿元(含),回购股份价格不超过人民币25元/股(含)。截至目前,公司通过回购专用 证券账户以集中竞价交易方式累计回购公司股份856.75万股,占公司回购完成时总股本的0.94%,最高 成交价为21.89元/股,最低成交价为13.41元/股,成交总金额为人民币1.51亿元(不含交易费用)。 ...